Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2433 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Opsona raises E18 million in series B financing

Novartis Venture Fund, Fountain Healthcare Partners, Inventages Venture Capital and Seroba Kernel Life Sciences all participated in the funding. Proceeds will support the advancement of Opsona’s clinical trials

Pharmos signs agreement with Reperio Pharmaceuticals

According to the company, these CB2-selective cannabinoids are synthetic compounds which belong to the class of nonclassical cannabinoids and thus display fewer of the undesired psychotropic and cardiovascular

Humana appoints new chief strategy officer

In his role, Mr Kusserow will be responsible for leading the company’s strategic planning function as well as its merger and acquisition and venture-capital activities. He will report

SenoRx Reports 2008 Results

Interest expense for the fourth quarter declined significantly to $26,000 against $267,000 a year ago, primarily due to the retirement of a subordinated debt facility with Escalate Capital